GEHC
GE HealthCare Technologies Inc.
Medical - Healthcare Information Services
Market Cap$27.90B
5Y Perf.+5.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
GEHC vs HOLX
Revenue, margins, valuation, and 5-year total return — side by side.
HOLX
Hologic, Inc.
Medical - Instruments & Supplies
Market Cap$16.97B
5Y Perf.+1.0%
GEHC vs HOLX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | GEHC | HOLX |
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Instruments & Supplies |
| Market Cap | $27.90B | $16.97B |
| Revenue (TTM) | $19.95B | $4.13B |
| Net Income (TTM) | $1.50B | $544M |
| Gross Margin | 42.5% | 52.8% |
| Operating Margin | 12.5% | 17.5% |
| Forward P/E | 12.4x | 17.2x |
| Total Debt | $10.00B | $2.63B |
| Cash & Equiv. | $4.51B | $1.96B |
GEHC vs HOLX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
GEHC
HOLX
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| GE HealthCare Techn… (GEHC) | 100 | 105.1 | +5.1% |
| Hologic, Inc. (HOLX) | 100 | 101.0 | +1.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEHC vs HOLX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: HOLX leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. GE HealthCare Technologies Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
GEHC
GE HealthCare Technologies Inc.
The Growth Play
GEHC is the clearest fit if your priority is growth exposure.
- Rev growth 4.8%, EPS growth 4.8%, 3Y rev CAGR 4.0%
- 4.8% revenue growth vs HOLX's 1.7%
- Lower P/E (12.4x vs 17.2x)
Best for: growth exposure
HOLX
Hologic, Inc.
The Income Pick
HOLX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.41
- 124.3% 10Y total return vs GEHC's 2.9%
- Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | GEHC | 4.8% revenue growth vs HOLX's 1.7% |
| Value | GEHC | Lower P/E (12.4x vs 17.2x) |
| Quality / Margins | HOLX | 13.2% margin vs GEHC's 7.5% |
| Stability / Safety | HOLX | Beta 0.41 vs GEHC's 1.37, lower leverage |
| Dividends | GEHC | 0.2% yield; 3-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | HOLX | +37.1% vs GEHC's -10.7% |
| Efficiency (ROA) | HOLX | 6.1% ROA vs GEHC's 4.1%, ROIC 9.4% vs 13.3% |
GEHC vs HOLX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
GEHC vs HOLX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLHOLXLAGGINGGEHC
GEHCGE HealthCare Technol…
1leads
HOLXHologic, Inc.
4leads
6 Total Categories
CATEGORYLEADERvs GEHCMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
HOLX5/6
Valuation MetricsMultiples, price ratios, and targets
GEHC5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
HOLX6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
HOLX6/6
Risk & VolatilityBeta, volatility, and downside exposure
HOLX2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
HOLX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 4.8x HOLX's $4.1B. HOLX is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to GEHC's 7.5%. On growth, GEHC holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | GEHCGE HealthCare Tec… | HOLXHologic, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $20.0B | $4.1B |
| EBITDAEarnings before interest/tax | $3.3B | $974M |
| Net IncomeAfter-tax profit | $1.5B | $544M |
| Free Cash FlowCash after capex | $1.5B | $1000M |
| Gross MarginGross profit ÷ Revenue | +42.5% | +52.8% |
| Operating MarginEBIT ÷ Revenue | +12.5% | +17.5% |
| Net MarginNet income ÷ Revenue | +7.5% | +13.2% |
| FCF MarginFCF ÷ Revenue | +7.6% | +24.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.4% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -30.9% | -9.2% |
HOLX leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
GEHC leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, GEHC trades at a 56% valuation discount to HOLX's 30.5x P/E. On an enterprise value basis, GEHC's 10.0x EV/EBITDA is more attractive than HOLX's 17.4x.
| Metric | GEHCGE HealthCare Tec… | HOLXHologic, Inc. |
|---|---|---|
| Market CapShares × price | $27.9B | $17.0B |
| Enterprise ValueMkt cap + debt − cash | $33.4B | $17.6B |
| Trailing P/EPrice ÷ TTM EPS | 13.48x | 30.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.40x | 17.21x |
| PEG RatioP/E ÷ EPS growth rate | 19.78x | — |
| EV / EBITDAEnterprise value multiple | 10.00x | 17.39x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 4.14x |
| Price / BookPrice ÷ Book value/share | 2.66x | 3.43x |
| Price / FCFMarket cap ÷ FCF | 18.53x | 18.44x |
GEHC leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
HOLX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $11 for HOLX. HOLX carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs GEHC's 4/9, reflecting strong financial health.
| Metric | GEHCGE HealthCare Tec… | HOLXHologic, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +14.4% | +11.0% |
| ROA (TTM)Return on assets | +4.1% | +6.1% |
| ROICReturn on invested capital | +13.3% | +9.4% |
| ROCEReturn on capital employed | +10.8% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.94x | 0.52x |
| Net DebtTotal debt minus cash | $5.5B | $667M |
| Cash & Equiv.Liquid assets | $4.5B | $2.0B |
| Total DebtShort + long-term debt | $10.0B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | 5.35x | 8.00x |
HOLX leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
HOLX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HOLX five years ago would be worth $11,582 today (with dividends reinvested), compared to $10,293 for GEHC. Over the past 12 months, HOLX leads with a +37.1% total return vs GEHC's -10.7%. The 3-year compound annual growth rate (CAGR) favors HOLX at -2.9% vs GEHC's -8.0% — a key indicator of consistent wealth creation.
| Metric | GEHCGE HealthCare Tec… | HOLXHologic, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -25.9% | +1.9% |
| 1-Year ReturnPast 12 months | -10.7% | +37.1% |
| 3-Year ReturnCumulative with dividends | -22.2% | -8.5% |
| 5-Year ReturnCumulative with dividends | +2.9% | +15.8% |
| 10-Year ReturnCumulative with dividends | +2.9% | +124.3% |
| CAGR (3Y)Annualised 3-year return | -8.0% | -2.9% |
HOLX leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
HOLX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than GEHC's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs GEHC's 68.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | GEHCGE HealthCare Tec… | HOLXHologic, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.37x | 0.41x |
| 52-Week HighHighest price in past year | $89.77 | $76.04 |
| 52-Week LowLowest price in past year | $58.75 | $52.81 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 32.1 | 69.1 |
| Avg Volume (50D)Average daily shares traded | 4.3M | 10.0M |
HOLX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates GEHC as "Buy" and HOLX as "Hold". Consensus price targets imply 36.9% upside for GEHC (target: $84) vs 3.9% for HOLX (target: $79). GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | GEHCGE HealthCare Tec… | HOLXHologic, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $84.00 | $79.00 |
| # AnalystsCovering analysts | 18 | 42 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | — |
| Dividend StreakConsecutive years of raises | 3 | — |
| Dividend / ShareAnnual DPS | $0.14 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +4.4% |
Insufficient data to determine a leader in this category.
Key Takeaway
HOLX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GEHC leads in 1 (Valuation Metrics).
Best OverallHologic, Inc. (HOLX)Leads 4 of 6 categories
Loading custom metrics...
GEHC vs HOLX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GEHC or HOLX a better buy right now?
For growth investors, GE HealthCare Technologies Inc.
(GEHC) is the stronger pick with 4. 8% revenue growth year-over-year, versus 1. 7% for Hologic, Inc. (HOLX). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate GE HealthCare Technologies Inc. (GEHC) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GEHC or HOLX?
On trailing P/E, GE HealthCare Technologies Inc.
(GEHC) is the cheapest at 13. 5x versus Hologic, Inc. at 30. 5x. On forward P/E, GE HealthCare Technologies Inc. is actually cheaper at 12. 4x.
03Which is the better long-term investment — GEHC or HOLX?
Over the past 5 years, Hologic, Inc.
(HOLX) delivered a total return of +15. 8%, compared to +2. 9% for GE HealthCare Technologies Inc. (GEHC). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus GEHC's +2. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GEHC or HOLX?
By beta (market sensitivity over 5 years), Hologic, Inc.
(HOLX) is the lower-risk stock at 0. 41β versus GE HealthCare Technologies Inc. 's 1. 37β — meaning GEHC is approximately 233% more volatile than HOLX relative to the S&P 500. On balance sheet safety, Hologic, Inc. (HOLX) carries a lower debt/equity ratio of 52% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GEHC or HOLX?
By revenue growth (latest reported year), GE HealthCare Technologies Inc.
(GEHC) is pulling ahead at 4. 8% versus 1. 7% for Hologic, Inc. (HOLX). On earnings-per-share growth, the picture is similar: GE HealthCare Technologies Inc. grew EPS 4. 8% year-over-year, compared to -25. 0% for Hologic, Inc.. Over a 3-year CAGR, GEHC leads at 4. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GEHC or HOLX?
Hologic, Inc.
(HOLX) is the more profitable company, earning 13. 8% net margin versus 10. 1% for GE HealthCare Technologies Inc. — meaning it keeps 13. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOLX leads at 17. 4% versus 13. 4% for GEHC. At the gross margin level — before operating expenses — HOLX leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GEHC or HOLX more undervalued right now?
On forward earnings alone, GE HealthCare Technologies Inc.
(GEHC) trades at 12. 4x forward P/E versus 17. 2x for Hologic, Inc. — 4. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEHC: 36. 9% to $84. 00.
08Which pays a better dividend — GEHC or HOLX?
In this comparison, GEHC (0.
2% yield) pays a dividend. HOLX does not pay a meaningful dividend and should not be held primarily for income.
09Is GEHC or HOLX better for a retirement portfolio?
For long-horizon retirement investors, Hologic, Inc.
(HOLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +124. 3% 10Y return). Both have compounded well over 10 years (HOLX: +124. 3%, GEHC: +2. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GEHC and HOLX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GEHC is a mid-cap deep-value stock; HOLX is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(GEHC: 7.4% · HOLX: 2.5%)Net Margin>
%
(GEHC: 7.5% · HOLX: 13.2%)P/E Ratio<
x
(GEHC: 13.5x · HOLX: 30.5x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.